Aardvark Therapeutics, Inc. releases third-quarter financial results, providing updates that may impact its growth and the pharmaceutical preparations industry.
| Name | Aardvark Therapeutics, Inc. |
|---|---|
| CIK | 0001774857 |
| Tickers | AARD |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 821606367 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (858) 225-7696 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Aardvark Therapeutics, Inc. releases third-quarter financial results, providing updates that may impact its growth and the pharmaceutical preparations industry.
Aardvark Therapeutics announces exploratory efficacy data from its HERO trial, potentially impacting the pharmaceutical preparations industry.
Aardvark Therapeutics has received FDA clearance for ARD-101, a treatment for hyperphagia in Prader-Willi Syndrome, marking a significant milestone for the company.
Aardvark Therapeutics has appointed Dr. David Zhang to its board, enhancing its leadership in pharmaceutical preparations and regulatory expertise.
120 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128212 | 005-94897 | 261560165 | 34 | 18227 | |||
| 2026-11-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-459373 | 001-42513 | 261549114 | 34 | 315098 | 1 | 1 |
| 2026-11-13 | 10-Q | 10-Q | 0001193125-26-458957 | 001-42513 | 261548682 | 34 | 9653159 | 1 | 1 | |
| 2026-11-10 | 4 | 4 | 0001193125-26-455757 | 18655 | ||||||
| 2026-11-10 | 4 | 4 | 0001193125-26-455737 | 18681 | ||||||
| 2026-11-10 | 4 | 4 | 0001193125-26-455719 | 18660 | ||||||
| 2026-10-23 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-429509 | 001-42513 | 261479968 | 34 | 11927901 | 1 | 1 |
| 2026-10-22 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-428943 | 001-42513 | 261479074 | 34 | 199478 | 1 | 1 |
| 2026-10-08 | 4 | 4 | 0001193125-26-418022 | 5546 | ||||||
| 2026-10-08 | 3 | 3 | 0001193125-26-418016 | 16630 | ||||||
| 2026-10-08 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-26-417935 | 001-42513 | 261450042 | 34 | 186894 | 1 | 1 |
| 2026-09-11 | 4 | 4 | 0001193125-26-389564 | 7093 | ||||||
| 2026-09-11 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009373 | 001-42513 | 261374998 | 33 | 6321 | |||
| 2026-09-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009316 | 001-42513 | 261371998 | 33 | 6140 | |||
| 2026-08-21 | 4 | 4 | 0001193125-26-361489 | 5520 | ||||||
| 2026-08-21 | 4 | 4 | 0001193125-26-361486 | 5497 | ||||||
| 2026-08-21 | 4 | 4 | 0001193125-26-361482 | 5504 | ||||||
| 2026-08-21 | 4 | 4 | 0001193125-26-361481 | 5596 | ||||||
| 2026-08-17 | 8-K | 8-K | 5.07 | 0001193125-26-354053 | 001-42513 | 261286766 | 34 | 175672 | 1 | 1 |
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-344987 | 001-42513 | 261264327 | 34 | 7248415 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-344978 | 001-42513 | 261264282 | 34 | 303109 | 1 | 1 |
| 2026-07-10 | ARS | ARS | 0001193125-26-300897 | 001-42513 | 261168853 | 34 | 5613840 | |||
| 2026-07-10 | DEF 14A | DEF 14A | 0001193125-26-300874 | 001-42513 | 261168773 | 34 | 12554769 | 1 | 1 | |
| 2026-06-29 | PRE 14A | PRE 14A | 0001193125-26-288409 | 001-42513 | 261135712 | 34 | 12191260 | 1 | 1 | |
| 2026-06-12 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-269377 | 001-42513 | 261086541 | 34 | 159237 | 1 | 1 |
| 2026-05-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-224069 | 001-42513 | 26979140 | 34 | 186315 | 1 | 1 |
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-210675 | 001-42513 | 26951283 | 34 | 7632647 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-210664 | 001-42513 | 26951246 | 34 | 280942 | 1 | 1 |
| 2026-04-03 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001083 | 333-294537 | 26839466 | 33 | 1783 | ||
| 2026-04-03 | 424B5 | 424B5 | 0001193125-26-142105 | 333-294537 | 26838089 | 33 | 894083 | |||
| 2026-03-30 | CORRESP | filename1.htm | 0001193125-26-131825 | 14518 | ||||||
| 2026-03-25 | UPLOAD | filename1.pdf | 0000000000-26-003024 | 333-294537 | 40157 | |||||
| 2026-03-24 | 8-K | 8-K | 1.01,9.01 | 0001193125-26-120164 | 001-42513 | 26783725 | 34 | 161454 | 1 | 1 |
| 2026-03-24 | S-8 | S-8 | 0001193125-26-120120 | 333-294546 | 26783694 | 33 | 390174 | 1 | 1 | |
| 2026-03-23 | S-3 | S-3 | 0001193125-26-119973 | 333-294537 | 26783197 | 33 | 3452109 | 1 | 1 | |
| 2026-03-23 | 10-K | 10-K | 0001193125-26-119770 | 001-42513 | 26782477 | 34 | 36833384 | 1 | 1 | |
| 2026-03-23 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-119727 | 001-42513 | 26782294 | 34 | 410252 | 1 | 1 |
| 2026-02-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-082787 | 001-42513 | 26700484 | 34 | 192952 | 1 | 1 |
| 2026-02-12 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-26-047757 | 001-42513 | 26623526 | 34 | 319105 | 1 | 1 |
| 2026-02-11 | 4 | 4 | 0001193125-26-047317 | 5415 | ||||||
| 2026-02-11 | 4 | 4 | 0001193125-26-047315 | 5440 | ||||||
| 2026-02-11 | 4 | 4 | 0001193125-26-047316 | 5439 | ||||||
| 2026-02-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-043764 | 001-42513 | 26613523 | 34 | 196395 | 1 | 1 |
| 2026-01-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-009862 | 001-42513 | 26524811 | 34 | 11924368 | 1 | 1 |
| 2025-12-12 | 4 | 4 | 0001193125-25-318070 | 4444 | ||||||
| 2025-12-12 | 4 | 4 | 0001193125-25-318069 | 5131 | ||||||
| 2025-12-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-314364 | 001-42513 | 251562564 | 34 | 218439 | 1 | 1 |
| 2025-11-13 | 10-Q | 10-Q | 0001193125-25-280260 | 001-42513 | 251479027 | 34 | 28774601 | 1 | 1 | |
| 2025-11-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-280235 | 001-42513 | 251478844 | 34 | 334275 | 1 | 1 |
| 2025-11-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-267402 | 001-42513 | 251455418 | 34 | 26554570 | 1 | 1 |
| 2025-11-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-264748 | 001-42513 | 251449403 | 34 | 2529940 | 1 | 1 |
| 2025-10-16 | 4 | 4 | 0001193125-25-241647 | 7560 | ||||||
| 2025-10-16 | 4 | 4 | 0001193125-25-241643 | 6895 | ||||||
| 2025-10-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-234722 | 001-42513 | 251383250 | 34 | 326982 | 1 | 1 |
| 2025-09-16 | 4 | 4 | 0001193125-25-204233 | 7625 | ||||||
| 2025-09-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007102 | 001-42513 | 251314370 | 33 | 6646 | |||
| 2025-09-12 | 4 | 4 | 0001193125-25-202490 | 9639 | ||||||
| 2025-09-10 | 4 | 4 | 0001193125-25-200226 | 5053 | ||||||
| 2025-09-03 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-112645 | 001-42513 | 251287531 | 34 | 9124712 | 1 | 1 |
| 2025-09-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-006593 | 001-42513 | 251285433 | 33 | 5866 | |||
| 2025-08-29 | 4 | 4 | 0001193125-25-192747 | 7567 | ||||||
| 2025-08-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-006518 | 001-42513 | 251274104 | 33 | 5087 | |||
| 2025-08-13 | S-8 | S-8 | 0000950170-25-108176 | 333-289592 | 251213128 | 33 | 371131 | 1 | 1 | |
| 2025-08-13 | 10-Q | 10-Q | 0000950170-25-108116 | 001-42513 | 251212445 | 34 | 18315964 | 1 | 1 | |
| 2025-08-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-108082 | 001-42513 | 251212241 | 34 | 330264 | 1 | 1 |
| 2025-08-12 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-107320 | 001-42513 | 251206800 | 34 | 470530 | 1 | 1 |
| 2025-06-13 | 4 | 4 | 0000950170-25-086147 | 5410 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086146 | 5354 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086145 | 5438 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086141 | 5234 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086140 | 5372 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086143 | 5413 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086139 | 5436 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086138 | 5214 | ||||||
| 2025-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-072801 | 005-94897 | 25954905 | 34 | 113739 | |||
| 2025-05-14 | 10-Q | 10-Q | 0000950170-25-071560 | 001-42513 | 25946696 | 34 | 8676235 | 1 | 1 | |
| 2025-05-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-071477 | 001-42513 | 25946142 | 34 | 291836 | 1 | 1 |
| 2025-03-31 | 10-K | 10-K | 0000950170-25-047835 | 001-42513 | 25794187 | 34 | 26832605 | |||
| 2025-03-31 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-047769 | 001-42513 | 25793594 | 34 | 292342 | 1 | 1 |
| 2025-02-24 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-016592 | 005-94897 | 25658495 | 34 | 27679 | |||
| 2025-02-24 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-005246 | 005-94897 | 25657202 | 34 | 19469 | |||
| 2025-02-24 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-016266 | 005-94897 | 25654135 | 34 | 11445 | |||
| 2025-02-19 | 4 | 4 | 0000950170-25-023409 | 22553 | ||||||
| 2025-02-19 | 4 | 4 | 0000950170-25-023311 | 7791 | ||||||
| 2025-02-19 | 4 | 4 | 0000950170-25-023287 | 13285 | ||||||
| 2025-02-19 | 4 | 4 | 0000950170-25-023253 | 8959 | ||||||
| 2025-02-19 | 4 | 4 | 0000950170-25-023243 | 8318 | ||||||
| 2025-02-19 | 4 | xslF345X05/form4.xml | 0000929638-25-000822 | 11672 | ||||||
| 2025-02-14 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-25-027245 | 001-42513 | 25628062 | 34 | 206011 | 1 | 1 |
| 2025-02-13 | S-8 | S-8 | 0001193125-25-026172 | 333-284915 | 25621399 | 33 | 340314 | |||
| 2025-02-13 | 424B4 | 424B4 | 0001193125-25-026060 | 333-284440 | 25620211 | 33 | 8927322 | |||
| 2025-02-12 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000422 | 333-284440 | 25616921 | 33 | 1790 | ||
| 2025-02-12 | 3 | 3 | 0000950170-25-019187 | 14302 | ||||||
| 2025-02-12 | 3 | 3 | 0000950170-25-019173 | 15031 | ||||||
| 2025-02-12 | 3 | 3 | 0000950170-25-019166 | 21572 | ||||||
| 2025-02-12 | 3 | 3 | 0000950170-25-019165 | 17915 | ||||||
| 2025-02-12 | 3 | 3 | 0000950170-25-019159 | 16621 | ||||||
| 2025-02-12 | 3 | 3 | 0000950170-25-019156 | 15703 | ||||||
| 2025-02-12 | 3 | 3 | 0000950170-25-019150 | 8239 | ||||||
| 2025-02-12 | 3 | 3 | 0000950170-25-019145 | 16488 | ||||||
| 2025-02-12 | 3 | 3 | 0000950170-25-019119 | 18447 | ||||||
| 2025-02-12 | 3 | 3 | 0000950170-25-019108 | 18794 | ||||||
| 2025-02-12 | 3 | xslF345X02/form3.xml | 0000929638-25-000679 | 7529 | ||||||
| 2025-02-12 | CERT | 8A_Cert_AARD.pdf | 0001354457-25-000098 | 001-42513 | 25614054 | 34 | 249025 | |||
| 2025-02-10 | 8-A12B | 8-A12B | 0001193125-25-023571 | 001-42513 | 25605656 | 34 | 13902 | |||
| 2025-02-10 | CORRESP | filename1.htm | 0001193125-25-023550 | 10855 | ||||||
| 2025-02-10 | CORRESP | filename1.htm | 0001193125-25-023543 | 7915 | ||||||
| 2025-02-06 | S-1/A | S-1/A | 0001193125-25-021764 | 333-284440 | 25597262 | 33 | 10538270 | |||
| 2025-01-31 | CORRESP | filename1.htm | 0001193125-25-018390 | 95975 | ||||||
| 2025-01-23 | S-1 | S-1 | 0001193125-25-011499 | 333-284440 | 25550825 | 33 | 9941617 | |||
| 2024-12-23 | DRS/A | filename1.htm | 0000950123-24-012332 | 377-07518 | 241569089 | 33 | 9094953 | |||
| 2024-12-20 | DRSLTR | filename1.htm | 0000950123-24-012333 | 23110 | ||||||
| 2024-12-10 | UPLOAD | filename1.pdf | 0000000000-24-013594 | 377-07518 | 43839 | |||||
| 2024-11-27 | DRSLTR | filename1.htm | 0000950123-24-012128 | 50573 | ||||||
| 2024-11-27 | DRS/A | filename1.htm | 0000950123-24-012127 | 377-07518 | 241512535 | 33 | 8339435 | |||
| 2024-11-21 | UPLOAD | filename1.pdf | 0000000000-24-012962 | 377-07518 | 56942 | |||||
| 2024-10-24 | DRS | filename1.htm | 0000950123-24-009882 | 377-07518 | 241390964 | 33 | 7963820 | |||
| 2024-05-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001774857-24-000001 | 021-513397 | 24949455 | 33 | 9789 | ||
| 2021-06-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001774857-21-000002 | 021-402004 | 21999955 | 33 | 9705 | ||
| 2019-05-24 | D | xslFormDX01/primary_doc.xml | 06b | 0001774857-19-000001 | 021-340343 | 19852686 | 33 | 7358 |
One latest value per concept from companyfacts (150 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 21.89M | 2026-11-02 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 162.90M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 137,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 5.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 228.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 5.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 5.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 2.37M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001193125-25-280260 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 0 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-13 | 0001193125-25-280260 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 3.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | Assets | Assets | USD | 64.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 64.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 81,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 0 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 62.86M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 28.42M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0000950170-25-071560 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 28.44M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0000950170-25-071560 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 28.73M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-210675 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 28.75M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-210675 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 60.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 60.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 60.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 13.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 4.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 490.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 21.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 21.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -55.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 138,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 38.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 3.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DeferredTaxAssetsInvestments | Deferred Tax Assets, Investments | USD | 1.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 23.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 1.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 38.52M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 7,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 32,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.52 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.52 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.274 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | -0.017 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.024 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.092 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 3.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 14.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 15.77M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -12.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 221,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -136,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 1.37M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 5.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -483,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -3.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -315,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -2.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | InterestAndDividendIncomeOperating | Interest and Dividend Income, Operating | USD | 2.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | InvestmentIncomeInterestAndDividend | Investment Income, Interest and Dividend | USD | 2.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 10.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 458,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 458,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 17,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | Liabilities | Liabilities | USD | 7.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 64.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 7.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 288,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 63.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -50.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -55.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 2.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 57.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -57.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 900,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 441,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 413,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 159,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 532,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.07 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 359,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 162,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax | USD | -81,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -81,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 636,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 259,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments | Proceeds from Sale, Maturity and Collection of Short-term Investments | USD | 63.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 29,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 42.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -171.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 446,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 5.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 1.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 8.84 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 13,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 57.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.118 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 2,950 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 126.76M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 259,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 87.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 29,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -19,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 2.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 1.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 86,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 20.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001193125-26-119770 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 21.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 5,402 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 21.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-458957 |